Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...
A celebratory finish for Winchester’s Danny Collins, Phillips Andover hockey in NEPSAC Large final
Skating for Phillips Andover Academy in a postgraduate season, the former Winchester captain scored twice in a 4-2 victory over Westminster for the program’s first NEPSAC Martin/Earl Large ...
The ICC Champions Trophy final might have gone India's way but New Zealand star Glenn Phillips also made headlines for the exceptional catch he produced in the final, to dismiss Shubman Gill.
Leeds have reportedly come to a verbal agreement which will see Kalvin Phillips re-join the club, after coming close to landing him a year ago. Phillips was one of the very best players at Leeds ...
Editors' Blog / Analysis & Opinion News Live Blog Morning Memo Cafe / outside voices & analysis Muckraker / scandal & investigations Prime / Member Exclusives Podcast Features Memberships View ...
Well-known to followers of the blogosphere and seekers of intelligent, percipient commentary on public policy, Kevin Drum passed away Friday after a long battle with multiple myeloma, a cancer of ...
Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...
Jonty Rhodes acknowledges Glenn Phillips as the best fielder of this generation after Phillips' exceptional performances in the ICC Champions Trophy 2025. Phillips amazed fans with stunning ...
Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. Morten Lammert will join Roche as its ...
Former Sunderland star Kevin Phillips had plenty of admiration for one star player from the 1999/00 campaign. Sunderland’s golden 1999/00 Premier League season saw the Black Cats finish 7th in the ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest ...
Novo announced results from a new weight loss drug that failed to meet expectations. Despite the results, the company is still in a strong position to continue leading the weight loss space. Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results